Related Experiment Video
Updated: Jul 13, 2025
11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.4K
Gene addition for beta thalassemia.
1Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Annals of the New York Academy of Sciences
|October 13, 2023
Summary
Gene therapy offers a potential cure for transfusion-dependent beta thalassemia, addressing the limitations of stem cell transplants. This review discusses lentiviral vector efficacy and safety in ongoing clinical trials.
Area of Science:
- Hematology
- Gene Therapy
- Genetic Blood Disorders
Background:
- Transfusion-dependent beta thalassemia presents a significant health burden, impacting quality of life.
- Allogeneic hematopoietic stem cell transplantation is curative but limited by donor availability and transplant risks.
- Gene addition using autologous CD34+ cells offers a promising alternative treatment.
Approach:
- Review of ongoing clinical trials utilizing lentiviral vectors for beta-globin gene addition.
- Focus on specific vector constructs: Lentiglobin BB305, GLOBE, and TNS9.3.55.
- Analysis of efficacy and safety data from these gene therapy trials.
Key Points:
- Gene addition via lentiviral vectors targets autologous CD34+ cells.
- Clinical trials are evaluating the therapeutic potential of beta-globin gene transfer.
- Safety and efficacy data are crucial for advancing this treatment modality.
Conclusions:
- Lentiviral gene therapy represents a viable alternative to allogeneic stem cell transplantation for beta thalassemia.
- Ongoing trials are generating essential data on the long-term outcomes of this approach.
- Further research is needed to optimize gene therapy protocols and expand patient access.
More Related Videos
Related Concept Videos
01:49Multiple Allele Traits
34.3K
The Concept of Multiple Allelism
34.3K
02:18Alternative RNA Splicing
21.2K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.2K
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
01:22Bone Marrow Sampling and Transplants
342
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
342
01:31Translation
14.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.9K
01:30General Transcription Factors
5.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K